Memorial Community Care | |
1423 Seventh Street, Aurora, Nebraska 68818 | |
(402) 694-8230 | |
Name | Memorial Community Care |
---|---|
Location | 1423 Seventh Street, Aurora, Nebraska |
Certified By | Medicaid |
No. of Certified Beds | 48 |
Occupancy Rate | 71.46% |
Medicare ID (CCN) | 28E191 |
Legal Business Name | Legal Business Name Not Available |
Ownership Type | For Profit - Corporation |
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
A drug initially used to treat mild to moderate Alzheimer's disease improved the memory and global function of people with severe Alzheimer's disease and was safe and effective, according to a study published in the July 31, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
"Nearly 30 years into the AIDS epidemic, we are able to access our progress in tackling the disease with both increased knowledge and the benefit of hindsight," former UNAIDS Executive Director Peter Piot of Imperial College London, who also serves as an adviser on global health strategy to the Bill & Melinda Gates Foundation; Michel Kazatchkine, executive director of the Global Fund To Fight AIDS, Tuberculosis and Malaria; Mark Dybul of the O'Neill Institute for National and Global Health Law at Georgetown University and former U.S. Global AIDS Coordinator; and Julian Lob-Levyt of the GAVI Alliance write in a Lancet opinion piece.
Paradoxically, as overall firearm ownership decreased in U.S. households with young children from 1976 to 2016, the proportion of these families who owned handguns increased.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 1.61 | 14.46 |
Percentage of long-stay residents who lose too much weight | 3.15 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 42.86 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.24 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.7 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 4.2 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.7 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 6.9 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 7.46 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 10.24 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 0 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 0 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 100 | 82.93 |
News Archive
A drug initially used to treat mild to moderate Alzheimer's disease improved the memory and global function of people with severe Alzheimer's disease and was safe and effective, according to a study published in the July 31, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
"Nearly 30 years into the AIDS epidemic, we are able to access our progress in tackling the disease with both increased knowledge and the benefit of hindsight," former UNAIDS Executive Director Peter Piot of Imperial College London, who also serves as an adviser on global health strategy to the Bill & Melinda Gates Foundation; Michel Kazatchkine, executive director of the Global Fund To Fight AIDS, Tuberculosis and Malaria; Mark Dybul of the O'Neill Institute for National and Global Health Law at Georgetown University and former U.S. Global AIDS Coordinator; and Julian Lob-Levyt of the GAVI Alliance write in a Lancet opinion piece.
Paradoxically, as overall firearm ownership decreased in U.S. households with young children from 1976 to 2016, the proportion of these families who owned handguns increased.
› Verified 6 days ago
Westfield Quality Care Of Aurora Location: 1313 1st Street, Aurora, Nebraska 68818 Phone: (402) 694-2128 | |